Trevi Therapeutics's total assets for Q3 2025 were $199.36M, a decrease of -4.31% from the previous quarter. TRVI total liabilities were $9.57M for the fiscal quarter, a -2.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.